Growth Metrics

Boston Scientific (BSX) Cash from Operations Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 5.31%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 22.35%
Dec 31, 2025 19.12%
Sep 30, 2025 41.90%
Jun 30, 2025 61.20%
Mar 31, 2025 124.58%
Dec 31, 2024 44.96%
Sep 30, 2024 29.16%
Jun 30, 2024 8.13%
Mar 31, 2024 -16.73%
Dec 31, 2023 12.45%
Sep 30, 2023 2.77%
Jun 30, 2023 34.74%
Mar 31, 2023 64.70%
Dec 31, 2022 5.26%
Sep 30, 2022 -2.17%
Jun 30, 2022 1.68%
Mar 31, 2022 -29.38%
Dec 31, 2021 193.02%
Sep 30, 2021 -2.45%
Jun 30, 2021 53.20%
Mar 31, 2021 13.74%
Dec 31, 2020 -0.54%
Sep 30, 2020 12.47%
Jun 30, 2020 -3.25%
Mar 31, 2020 -122.40%
Dec 31, 2019 0.78%
Sep 30, 2019 163.01%
Jun 30, 2019 -11.48%
Mar 31, 2019 44.50%
Dec 31, 2018 -64.37%
Sep 30, 2018 7.08%
Jun 30, 2018 -105.80%
Mar 31, 2018 43.90%
Dec 31, 2017 15.84%
Sep 30, 2017 9.32%
Jun 30, 2017 1.38%
Mar 31, 2017 -26.73%
Dec 31, 2016 34.96%
Sep 30, 2016 -28.53%
Jun 30, 2016 1.98%
Mar 31, 2016 -14.72%
Dec 31, 2015 2.59%
Sep 30, 2015 14.47%
Jun 30, 2015 -47.17%
Mar 31, 2015 -43.08%
Dec 31, 2014 8.03%
Sep 30, 2014 -1.86%
Jun 30, 2014 -9.93%
Mar 31, 2014 59.28%
Dec 31, 2013 -15.08%
Sep 30, 2013 58.64%
Jun 30, 2013 11.55%
Mar 31, 2013 38.53%
Dec 31, 2012 47.09%
Sep 30, 2012 -17.48%
Jun 30, 2012 -0.96%
Mar 31, 2012 -6.70%